184 related articles for article (PubMed ID: 15316933)
21. Mutational analysis of p53 in 16 cases of acute lymphoblastic leukemia and Burkitt's lymphoma.
Nomdedéu JF; Lete I; Baiget M; Lasa A; Estivill C; Rubiol E; Badell I; Pardo N; Cubells J; Mateu R; Brunet S; Bordes R; Soler J
Haematologica; 1997; 82(5):550-4. PubMed ID: 9407719
[TBL] [Abstract][Full Text] [Related]
22. Analysis of p53 mutations in cells taken from paraffin-embedded tissue sections of ductal carcinoma in situ and atypical ductal hyperplasia of the breast.
Keohavong P; Gao WM; Mady HH; Kanbour-Shakir A; Melhem MF
Cancer Lett; 2004 Aug; 212(1):121-30. PubMed ID: 15246568
[TBL] [Abstract][Full Text] [Related]
23. The balanced induction of K-ras codon 12 and 13 mutations in mucosa differs from their ratio in neoplastic tissues.
Kraus MC; Seelig MH; Linnemann U; Berger MR
Int J Oncol; 2006 Oct; 29(4):957-64. PubMed ID: 16964391
[TBL] [Abstract][Full Text] [Related]
24. K-ras mutational analysis of polyclonal colorectal cancers identifies uniclonal circulating tumor cells.
Thebo JS; Senagore AJ; Krygier S; Luchtefeld MA
Am Surg; 2001 Aug; 67(8):802-5. PubMed ID: 11510588
[TBL] [Abstract][Full Text] [Related]
25. Molecular mechanisms underlying the tumorigenesis of colorectal adenomas: correlation to activated K-ras oncogene.
Wang JY; Wang YH; Jao SW; Lu CY; Kuo CH; Hu HM; Hsieh JS; Chong IW; Cheng TL; Lin SR
Oncol Rep; 2006 Dec; 16(6):1245-52. PubMed ID: 17089045
[TBL] [Abstract][Full Text] [Related]
26. Alport syndrome. Molecular genetic aspects.
Hertz JM
Dan Med Bull; 2009 Aug; 56(3):105-52. PubMed ID: 19728970
[TBL] [Abstract][Full Text] [Related]
27. A distinct mutational spectrum of p53 and K-ras genes in lung cancer of workers with silicosis.
Liu B; Guan R; Zhou P; Miao Q; Wang H; Fu D; You B
J Environ Pathol Toxicol Oncol; 2000; 19(1-2):1-7. PubMed ID: 10905501
[TBL] [Abstract][Full Text] [Related]
28. Radiation-induced cutaneous carcinoma of the head and neck: is there an early role for p53 mutations?
Franchi A; Massi D; Gallo O; Santucci M; Porfirio B
Clin Exp Dermatol; 2006 Nov; 31(6):793-8. PubMed ID: 16824052
[TBL] [Abstract][Full Text] [Related]
29. Heterogeneity within and between primary colorectal carcinomas and matched metastases as revealed by analysis of Ki-ras and p53 mutations.
Albanese I; Scibetta AG; Migliavacca M; Russo A; Bazan V; Tomasino RM; Colomba P; Tagliavia M; La Farina M
Biochem Biophys Res Commun; 2004 Dec; 325(3):784-91. PubMed ID: 15541358
[TBL] [Abstract][Full Text] [Related]
30. Humoral response to p53 is associated with conserved domains II and IV mutations in human colorectal cancer: a case-control study in Taiwan.
Wu CM; Tang R; Chen JR; Wu MC; Chien HT; Changchien CR; Hsieh LL
Oncol Rep; 2004 Nov; 12(5):1045-51. PubMed ID: 15492791
[TBL] [Abstract][Full Text] [Related]
31. Clinical significance in molecular detection of p53 mutation in serum of patients with colorectal carcinoma.
Ito T; Kaneko K; Makino R; Konishi K; Kurahashi T; Ito H; Katagiri A; Kushima M; Kusano M; Mitamura K; Imawari M
Oncol Rep; 2003; 10(6):1937-42. PubMed ID: 14534722
[TBL] [Abstract][Full Text] [Related]
32. Detection of the mutated K-Ras biomarker in colorectal carcinoma.
Doolittle BR; Emanuel J; Tuttle C; Costa J
Exp Mol Pathol; 2001 Jun; 70(3):289-301. PubMed ID: 11418008
[TBL] [Abstract][Full Text] [Related]
33. Multiplex PCR/LDR for detection of K-ras mutations in primary colon tumors.
Khanna M; Park P; Zirvi M; Cao W; Picon A; Day J; Paty P; Barany F
Oncogene; 1999 Jan; 18(1):27-38. PubMed ID: 9926917
[TBL] [Abstract][Full Text] [Related]
34. Prediction of Biologic Aggressiveness in Colorectal Cancer by p53/K-ras-2 Topographic Genotyping.
Finkelstein SD; Przygodzki R; Pricolo VE; Sakallah SA; Swalsky PA; Bakker A; Lanning R; Bland KI; Cooper DL
Mol Diagn; 1996 Jun; 1(1):5-28. PubMed ID: 10330194
[TBL] [Abstract][Full Text] [Related]
35. Analysis of Ki-ras gene mutations within the same tumor using a single tumor crypt in colorectal carcinomas.
Ishii M; Sugai T; Habano W; Nakamura S
J Gastroenterol; 2004 Jun; 39(6):544-9. PubMed ID: 15235871
[TBL] [Abstract][Full Text] [Related]
36. ras mutations are associated with aggressive tumor phenotypes and poor prognosis in thyroid cancer.
Garcia-Rostan G; Zhao H; Camp RL; Pollan M; Herrero A; Pardo J; Wu R; Carcangiu ML; Costa J; Tallini G
J Clin Oncol; 2003 Sep; 21(17):3226-35. PubMed ID: 12947056
[TBL] [Abstract][Full Text] [Related]
37. P53 mutation analysis of colorectal liver metastases: relation to actual survival, angiogenic status, and p53 overexpression.
de Jong KP; Gouw AS; Peeters PM; Bulthuis M; Menkema L; Porte RJ; Slooff MJ; van Goor H; van den Berg A
Clin Cancer Res; 2005 Jun; 11(11):4067-73. PubMed ID: 15930341
[TBL] [Abstract][Full Text] [Related]
38. TP53 mutations and S-phase fraction but not DNA-ploidy are independent prognostic indicators in laryngeal squamous cell carcinoma.
Russo A; Corsale S; Agnese V; Macaluso M; Cascio S; Bruno L; Surmacz E; Dardanoni G; Valerio MR; Vieni S; Restivo S; Fulfaro F; Tomasino RM; Gebbia N; Bazan V
J Cell Physiol; 2006 Jan; 206(1):181-8. PubMed ID: 15965904
[TBL] [Abstract][Full Text] [Related]
39. [Detection of genetic mutations in clinical specimens from cancer patients: comparison of NIRCA and SSCP scanning methods].
Botezatu IV; Kondratova VN; Cherkes VL; Barsukov IuA; Aliev VE; Shelepov VP; Likhtenshteĭn AV
Vopr Onkol; 2007; 53(5):549-53. PubMed ID: 18154119
[TBL] [Abstract][Full Text] [Related]
40. Patterns of K-ras codon 12 and 13 mutations found in pancreatic adenocarcinoma of 30 Chinese patients by microdissection, PCR and direct sequencing.
Wei S; Liang Z; Gao J; Wu S; Zhu H; Liu H; Liu T
J Gastroenterol Hepatol; 2005 Jan; 20(1):67-72. PubMed ID: 15610449
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]